Publisher
Springer International Publishing
Reference102 articles.
1. Agabio R, Sinclair JM, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, De La Selle P, Franchitto N, Garbutt JC, Haber PS, Heydtmann M, Jaury P, Lingford-Hughes AR, Morley KC, Muller CA, Owens L, Pastor A, Paterson LM, Pelissier F, Rolland B, Stafford A, Thompson A, Van Den Brink W, De Beaurepaire R, Leggio L. Baclofen for the treatment of alcohol use disorder: the Cagliari statement. Lancet Psychiatry. 2018;5:957–60.
2. Ahuja T, Mgbako O, Katzman C, Grossman A. Phenibut (beta-phenyl-gamma-aminobutyric acid) dependence and management of withdrawal: emerging nootropics of abuse. Case Rep Psychiatry. 2018;2018:9864285.
3. Alho H. Opioid agonist diversion in opioid dependence treatment. In: El-Guebaly N, Carrà G, Galanter M, editors. Textbook of addiction treatment: international perspectives. New York: Springer; 2015.
4. Arfken CL, Cicero TJ. Postmarketing surveillance for drug abuse. Drug Alcohol Depend. 2003;70:S97–105.
5. Ator NA. Contributions of GABAA receptor subtype selectivity to abuse liability and dependence potential of pharmacological treatments for anxiety and sleep disorders. CNS Spectr. 2005;10:31–9.